Discovery and development of small molecule therapeutics targeting protein misfolding diseases11-50 Employees
- B2B
- Growth StageExpanding market presence
- Top InvestorsThis company has received a significant amount of investment from top investors
People at Protego Biopharma
Xin Jiang
